The role of G3BP1 in mutant SOD1-mediated familial ALS
G3BP1 在突变 SOD1 介导的家族性 ALS 中的作用
基本信息
- 批准号:9244982
- 负责人:
- 金额:$ 22.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAmyotrophic Lateral SclerosisAppearanceApplications GrantsBinding ProteinsBiological ModelsCell Culture TechniquesCo-ImmunoprecipitationsCollaborationsCuprozinc Superoxide DismutaseCytoplasmic GranulesCytoplasmic InclusionDataDefectDiseaseDrosophila genusEtiologyFutureGene MutationGenesGeneticHeat-Shock ResponseHomologous GeneHumanImmunoprecipitationIn VitroInheritedLinkMediatingMessenger RNAMetabolismModelingMolecularMotor NeuronsMuscle WeaknessMuscular AtrophyMutagenesisMutateMutationNeurodegenerative DisordersOutcomeOxidative StressPathogenesisPathway interactionsPatientsPhenotypePlayPreventive measureProcessProteinsRNARNA BindingReagentReportingResearchResolutionRibonucleosidesRibosomesRoleSCA2 proteinSOD2 geneSamplingSpinal CordStressSurfaceSymptomsTestingTimeToxic effectTranscriptTransgenic MiceTransgenic OrganismsTranslationsabstractingbasecrosslinkdesignflyin vitro Modelin vivoinsightmatrin 3motor neuron degenerationmouse modelmutantneuron lossnoveloverexpressionprotein TDP-43ras GTPase-Activating Proteinsresearch studyresponse
项目摘要
Abstract
Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease or ALS is a progressive and fatal
neurodegenerative disease with no cure available. In order to develop effective preventive measures or cures,
we have to gain a better understanding of the molecular pathogenesis of ALS. A general symptom of ALS is
muscle wasting caused by motor neuron loss. In familial ALS, the disease is caused by inherited gene
mutations. The first gene whose mutations were identified to cause ALS encodes the Cu/Zn superoxide
dismutase SOD1. It is still not fully understood how the mutations in SOD1 cause toxicity in ALS. Several other
genes whose mutations cause ALS encode RNA metabolism regulators whose known functions are seemingly
unrelated to that of SOD1. The convergence of these two pathogenic pathways in ALS is still unclear.
The Ras GTPase-activating protein-binding protein G3BP1 is known to regulate the stability and
translation of messenger RNAs. It is also a critical regulator of stress granule dynamics. Stress granules form
in response to challenges such as oxidative stress and heat shock. Stress granules sequester temporarily
dispensable messenger RNAs in translationally inactive form, freeing up ribosomes for the translation of
transcripts that are essential to survive the stress.
ALS mutants of SOD1 form cytoplasmic inclusions. We found that the mutant SOD1 inclusions
contained G3BP1. We also found an RNA independent interaction between mutant SOD1 and G3BP1. Our
hypothesis is that G3BP1 represents a critical link between the ALS mutations in SOD1 and the
pathological alterations in RNA metabolism.
Aim 1 of the grant proposal will determine the molecular details of the ALS mutant SOD1-G3BP1
interaction in cell culture and in vitro models. Aim 2 will determine the effect of ALS mutants of SOD1 on stress
granule dynamics and G3BP1 RNA binding in cell culture and transgenic mouse models. Aim 3 will test the
role of G3BP1 and the Drosophila G3BP1 homolog Rasputin/Rin in the toxicity of transgenic human SOD1 in a
fly model. The findings are expected to provide important insight into the mechanism by which SOD1 mutations
cause toxicity and perturb RNA metabolism.
摘要
肌萎缩侧索硬化症,也被称为Lou Gehrig病或ALS,是一种进行性和致命性的
无法治愈的神经退行性疾病。为了制定有效的预防措施或治疗方法,
我们必须更好地了解ALS的分子发病机制。肌萎缩侧索硬化的一个普遍症状是
运动神经元丢失引起的肌肉萎缩。家族性肌萎缩侧索硬化症是由遗传基因引起的
突变。第一个被发现突变导致肌萎缩侧索硬化症的基因编码了铜/锌超氧化物
歧化酶SOD1.目前还不完全清楚SOD1的突变是如何导致ALS的毒性的。其他几个
突变导致肌萎缩侧索硬化症的基因编码RNA新陈代谢调节器,其已知功能似乎是
与SOD1无关。这两条致病途径在肌萎缩侧索硬化症中的趋同尚不清楚。
已知的Ras GTP酶激活蛋白结合蛋白G3BP1调节细胞的稳定性和
信使RNA的翻译。它也是应力颗粒动力学的关键调节器。应激颗粒形态
以应对氧化应激和热休克等挑战。应激颗粒暂时隔离
翻译不活跃形式的可有可无的信使RNA,释放核糖体用于翻译
在压力下生存必不可少的成绩单。
SOD1的ALS突变体形成细胞质内含物。我们发现突变的SOD1包裹体
含有G3BP1。我们还发现突变体SOD1和G3BP1之间存在RNA不依赖的相互作用。我们的
假设G3BP1代表了SOD1中ALS突变和
核糖核酸代谢的病理改变。
拨款提案的目标1将确定ALS突变体SOD1-G3BP1的分子细节
细胞培养和体外模型中的相互作用。目标2将确定SOD1的ALS突变体对应激的影响
细胞培养和转基因小鼠模型中颗粒动力学和G3BP1 RNA结合。目标3将测试
G3BP1和果蝇G3BP1同源物Rasputin/Rin在转基因人SOD1毒性中的作用
飞行模特。这些发现有望为SOD1突变的机制提供重要的见解
造成毒性和干扰RNA新陈代谢。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jozsef Gal其他文献
Jozsef Gal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jozsef Gal', 18)}}的其他基金
The role of G3BP1 in mutant SOD1-mediated familial ALS
G3BP1 在突变型 SOD1 介导的家族性 ALS 中的作用
- 批准号:
9332487 - 财政年份:2016
- 资助金额:
$ 22.58万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 22.58万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 22.58万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 22.58万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Fellowship